Aethlon Medical Analyst Ratings
Aethlon Medical Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/24/2023 | 1542.86% | HC Wainwright & Co. | $90 → $23 | Maintains | Buy |
11/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
06/25/2021 | 542.86% | HC Wainwright & Co. | $5 → $9 | Maintains | Buy |
06/01/2021 | 257.14% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
01/08/2021 | 328.57% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
What is the target price for Aethlon Medical (AEMD)?
The latest price target for Aethlon Medical (NASDAQ: AEMD) was reported by HC Wainwright & Co. on October 24, 2023. The analyst firm set a price target for $23.00 expecting AEMD to rise to within 12 months (a possible 1542.86% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aethlon Medical (AEMD)?
The latest analyst rating for Aethlon Medical (NASDAQ: AEMD) was provided by HC Wainwright & Co., and Aethlon Medical maintained their buy rating.
When is the next analyst rating going to be posted or updated for Aethlon Medical (AEMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
Is the Analyst Rating Aethlon Medical (AEMD) correct?
While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a maintained with a price target of $90.00 to $23.00. The current price Aethlon Medical (AEMD) is trading at is $1.40, which is out of the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/24/2023 | 1542.86% | HC Wainwright & Co. | $90 → $23 | Maintains | Buy |
11/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
06/25/2021 | 542.86% | HC Wainwright & Co. | $5 → $9 | Maintains | Buy |
06/01/2021 | 257.14% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
01/08/2021 | 328.57% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
2023 年 10 月 24 日 | 1542.86% | HC Wainwright & Co. | 90 美元 → 23 美元 | 維持 | 購買 |
11/15/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
06/25/2021 | 542.86% | HC Wainwright & Co. | 5 美元 → 9 美元 | 維持 | 購買 |
06/01/2021 | 257.14% | HC Wainwright & Co. | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
01/08/2021 | 328.57% | Maxim 集團 | → 6 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Aethlon Medical (AEMD)?
Aethlon Medical(AEMD)的目標價格是多少?
The latest price target for Aethlon Medical (NASDAQ: AEMD) was reported by HC Wainwright & Co. on October 24, 2023. The analyst firm set a price target for $23.00 expecting AEMD to rise to within 12 months (a possible 1542.86% upside). 2 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年10月24日公佈了艾思龍醫療(納斯達克股票代碼:AEMD)的最新目標股價。該分析公司將目標股價設定爲23.00美元,預計AEMD將在12個月內上漲至23.00美元(可能上漲1542.86%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Aethlon Medical (AEMD)?
Aethlon Medical(AEMD)的最新分析師評級是多少?
The latest analyst rating for Aethlon Medical (NASDAQ: AEMD) was provided by HC Wainwright & Co., and Aethlon Medical maintained their buy rating.
Aethlon Medical(納斯達克股票代碼:AEMD)的最新分析師評級由HC Wainwright & Co. 提供,艾思龍醫療維持買入評級。
When is the next analyst rating going to be posted or updated for Aethlon Medical (AEMD)?
Aethlon Medical(AEMD)的下一個分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Aethlon Medical的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Aethlon Medical的最後一次評級是在2023年10月24日提交的,因此您應該預計下一個評級將在2024年10月24日左右公佈。
Is the Analyst Rating Aethlon Medical (AEMD) correct?
分析師評級 Aethlon Medical (AEMD) 是否正確?
While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a maintained with a price target of $90.00 to $23.00. The current price Aethlon Medical (AEMD) is trading at is $1.40, which is out of the analyst's predicted range.
儘管評級是主觀的,並將發生變化,但艾世龍醫療(AEMD)的最新評級維持不變,目標股價爲90.00美元至23.00美元。Aethlon Medical(AEMD)目前的交易價格爲1.40美元,超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧